Quick Answer
Enveric Biosciences, Inc. reported Long-Term Debt of $0.00 for fiscal year 2018.
Enveric Biosciences, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2018 | $0.00 | -100.0% |
| 2017 | $1.13M | -26.4% |
| 2016 | $1.54M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2018 | $1.7K | -99.9% | -99.8% |
| June 30, 2018 | $926.9K | -30.5% | -9.9% |
| March 31, 2018 | $1.03M | +0.5% | -9.0% |
| December 31, 2017 | $1.13M | -26.4% | -28.2% |
| September 30, 2017 | $1.58M | +0.5% | +18.1% |
| June 30, 2017 | $1.33M | -75.8% | +30.3% |
| March 31, 2017 | $1.02M | -81.4% | -33.4% |
| December 31, 2016 | $1.54M | -69.3% | -1.9% |
- Enveric Biosciences, Inc. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- Over the 2016–2018 period, Enveric Biosciences, Inc.’s long-term debt has declined by 100.0% (from $1.54 million to $0.00).
- The most recent figure is from Enveric Biosciences, Inc.’s fiscal year 2018 report (Form 10-K), filed with the SEC on March 26, 2019.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: